| Literature DB >> 33088883 |
Alexander S Greenstein1, Jack Teitel2, David J Mitten2, Benjamin F Ricciardi3, Thomas G Myers3.
Abstract
BACKGROUND: Determining discharge disposition after total joint arthroplasty (TJA) has been a challenge. Advances in machine learning (ML) have produced computer models that learn by example to generate predictions on future events. We hypothesized a trained ML algorithm's diagnostic accuracy will be better than that of current predictive tools to predict discharge disposition after primary TJA.Entities:
Keywords: Arthroplasty; Artificial intelligence; Discharge; Machine learning
Year: 2020 PMID: 33088883 PMCID: PMC7567055 DOI: 10.1016/j.artd.2020.08.007
Source DB: PubMed Journal: Arthroplast Today ISSN: 2352-3441
Initial variables chosen for model development.
| Medical record number | Comorbidities |
| Service date | Asthma |
| Service location (hospital in system) | Atrial fibrillation |
| Gender | Coronary artery disease |
| Address | Congestive heart failure |
| City | Chronic obstructive pulmonary disease |
| State | Diabetes |
| Zip code | Hypertension |
| Length of stay | Obesity |
| Ethnic group | Chronic kidney disease |
| Race | Depression |
| Lives alone | Osteoporosis |
| Height | Chronic liver disease |
| Weight | Sickle cell |
| Previous skilled nursing facility admission | Hyperlipidemia |
| Previous surgery | |
| Age | |
| Insurance 1 | |
| Insurance 2 | |
| Diagnosis code 1 | |
| Diagnosis code 2 | |
| Diagnosis code 3 | |
| Provider | |
| Procedure |
Demographic distribution of training, validation, and testing cohorts.
| Joint (#) | Training cohort | Validation cohort | Testing cohort | |||
|---|---|---|---|---|---|---|
| TKA (936) | THA (755) | TKA (170) | THA (180) | TKA (615) | THA (837) | |
| Age (years) | 69 (42-90) | 67 (20-90) | 69 (47-88) | 66.5 (30-90) | 69 (47-90) | 65 (21-90) |
| Gender (% male) | 35.58% | 40.66 | 35.29% | 35.00% | 43.25% | 46.12% |
| Race % white | 89.64% | 90.20% | 85.29% | 92.78% | 90.89% | 92.59% |
| Race % black | 7.80% | 8.21% | 10% | 5.56% | 6.99% | 6.45% |
| Race % other | 2.56% | 1.59% | 4.71% | 1.66% | 2.12% | 0.96% |
| Ethnicity (% Hispanic) | 1.50% | 1.59% | 1.18% | 1.11% | 1.30% | 0.84% |
| Height (inches) | 65 (54-78.5) | 66 (54-78) | 65 (55.5-77) | 65.98 (57-75) | 65.98 (57-77) | 66.5 (54-77) |
| Weight (oz) | 3040 (1392-5392) | 2864 (1360-5600) | 3128 (1760-5168) | 2848 (1504-4843.2) | 3200 (1712-5040) | 2928 (1456-5288) |
| Previous SNF admission (% yes) | 37.67% | 25.03% | 36.47% | 21.67% | 7.48% | 4.78% |
| Laterality (% right) | 14.85% | 15.23% | 15.29% | 15.00% | 52.52% | 54.84% |
| Laterality (% left) | 12.39% | 16.03% | 14.71% | 12.22% | 47.15% | 44.44% |
| % Lives alone (% yes) | 10.35% | 10.20% | 7.65% | 10.00% | 6.99% | 7.65% |
Figure 1EMR-integrated discharge dashboard.
Figure 2Balanced ROC curve—the rate of true positives (true discharges to home) vs false-positive rates (algorithmically selected SNF discharge patients who were in fact discharged home).
Risk Assessment and Prediction Tool.
| Item | Value | Score |
|---|---|---|
| Age group(y) | 50-65 | 2 |
| 66-75 | 1 | |
| >75 | 0 | |
| Gender | Male | 2 |
| Female | 1 | |
| Ambulation (block = 200 m) | Two blocks or more | 2 |
| 1-2 blocks | 1 | |
| Housebound | 0 | |
| Walking aids | None | 2 |
| Single-point stick | 1 | |
| Crutches/frame | 0 | |
| Use of community support (home help, home nurse, meals on wheels) | None or 1 per week | 1 |
| Two or more per week | 0 | |
| Postoperative caregiver | Yes | 3 |
| No | 0 |
Summary of recent studies with discharge prediction tools.
| Study lead author | Discharge tool | Cohort | Accuracy | AUC | % Of cohort discharge to SNFs |
|---|---|---|---|---|---|
| The present study | ANN | Retrospective Institutional | 91.7% in the validation cohort | 0.97 in the validation cohort | 25% in the training cohort |
| 61.3% in the testing cohort | 0.80 in the testing cohort | 6.7% in the testing cohort | |||
| Ramkumar et al. [ | ANN | NIS—training | 69.4% in validation cohort | 0.76 in the validation cohort | 45.6% |
| OME—validation | 64.4% in testing cohort | 0.69 in the testing cohort | 47.1% | ||
| Gholson et al. [ | ACS-NSQIP | Retrospective multicenter | n/a | 0.70 (not validated) | n/a |
| Menendez et al. [ | AM-PAC | Retrospective institutional | n/a | 0.78 | 39% |
| Dibra et al. [ | RAPT | Retrospective institutional | 88%, however 52.2-78.7% in intermediate risk patients | n/a | 14% |
| Hansen et al. [ | RAPT | Prospective institutional | 78%, however 65.2% in intermediate risk patients | n/a | 15% |
| Slover et al. [ | RAPT | Prospective institutional | n/a; however, 28% of high-risk and 76% intermediate-risk patients discharge to home | n/a | 29.5% |
NIS, Nationwide Inpatient Sample; OME, orthopaedic minimal data set episode of care.